Total Payments
$1,701
2024 Payments
$1,003
Companies
18
Transactions
32
Payment Breakdown by Category
Food & Beverage$1,701 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,701 | 32 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $325.04 | 5 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $217.26 | 2 | $0 (2024) |
| Eisai Inc. | $190.68 | 4 | $0 (2024) |
| Jazz Pharmaceuticals Inc. | $125.00 | 1 | $0 (2023) |
| Lexicon Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2023) |
| Incyte Corporation | $124.98 | 1 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $121.84 | 1 | $0 (2024) |
| SK Life Science, Inc. | $80.60 | 3 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $59.36 | 2 | $0 (2024) |
| Lundbeck LLC | $54.65 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,003 | 20 | Teva Pharmaceuticals USA, Inc. ($225.30) |
| 2023 | $698.23 | 12 | Ipsen Biopharmaceuticals, Inc ($125.00) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $31.33 | General |
| Category: Rare Disease | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY, DARZALEX | Food and Beverage | In-kind items and services | $34.45 | General |
| Category: Oncology | ||||||
| 09/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: Central Nervous System | ||||||
| 09/12/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/09/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Neurology | ||||||
| 08/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $38.09 | General |
| Category: Central Nervous System | ||||||
| 07/16/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $32.87 | General |
| Category: Neurology | ||||||
| 07/12/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/21/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: Adenosine A2A Receptors | ||||||
| 06/10/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Neurology | ||||||
| 06/07/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: Rare Disease | ||||||
| 06/05/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $92.26 | General |
| Category: Oncology | ||||||
| 05/29/2024 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $124.98 | General |
| Category: Oncology | ||||||
| 05/23/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $123.88 | General |
| Category: Neurology | ||||||
| 05/15/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: Central Nervous System | ||||||
| 05/11/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: ONCOLOGY | ||||||
| 04/29/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $39.45 | General |
| Category: Central Nervous System | ||||||
| 03/25/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $27.12 | General |
| Category: NEUROLOGY | ||||||
| 03/19/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $33.35 | General |
| Category: Immunology and Neurology | ||||||
| 01/30/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Neuroscience | ||||||
| 11/20/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2023 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Adenosine A2A Receptors | ||||||
| 10/23/2023 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $33.11 | General |
| Category: Neurology | ||||||
| 10/09/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $27.53 | General |
| Category: NEUROLOGY | ||||||
| 10/02/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $28.59 | General |
About Thomas Han
Thomas Han is a Family healthcare provider based in Alhambra, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2022. The National Provider Identifier (NPI) number assigned to this provider is 1184348617.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Thomas Han has received a total of $1,701 in payments from pharmaceutical and medical device companies, with $1,003 received in 2024. These payments were reported across 32 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,701).
Ad
Practice Information
- Specialty Family
- Location Alhambra, CA
- Active Since 09/28/2022
- Last Updated 10/25/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1184348617
Products in Payments
- Austedo XR (Drug) $325.04
- Leqembi (Drug) $190.68
- Inpefa (Drug) $125.00
- Tazverik (Drug) $125.00
- VYXEOS (Drug) $125.00
- MONJUVI (Drug) $124.98
- LIBTAYO (Biological) $121.84
- Onivyde (Drug) $92.26
- ULTOMIRIS (Biological) $59.36
- VYEPTI (Biological) $54.65
- Nourianz (Drug) $48.13
- TECVAYLI (Biological) $34.45
- Gamunex-C (Biological) $33.35
- VYVGART HYTRULO (Drug) $33.11
- REXULTI (Drug) $25.87
- DALVANCE (Drug) $24.72
- AMYVID (Drug) $23.19
- TEFLARO (Drug) $19.85
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Alhambra
Ling Lee, N.p, N.P
Family — Payments: $14,173
Family $14,173
Jiae Kwak, Fnp, FNP
Family — Payments: $3,398
Family $3,398
Sabrina Liu
Family — Payments: $1,381
Family $1,381
Jinsook Kwack, Fnp, FNP
Family — Payments: $1,373
Family $1,373
Weizhen Li
Family — Payments: $1,115
Family $1,115
Tarra Mandel, Fnp, FNP
Family — Payments: $785.38
Family $785.38